Cargando…
Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus
BACKGROUND: Arginase competes with nitric oxide synthase for their common substrate L-arginine. Up-regulation of arginase in coronary artery disease (CAD) and diabetes mellitus may reduce nitric oxide bioavailability contributing to endothelial dysfunction and ischemia-reperfusion injury. Arginase i...
Autores principales: | Kövamees, Oskar, Shemyakin, Alexey, Pernow, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114552/ https://www.ncbi.nlm.nih.gov/pubmed/25072937 http://dx.doi.org/10.1371/journal.pone.0103260 |
Ejemplares similares
-
Local Arginase Inhibition during Early Reperfusion Mediates Cardioprotection via Increased Nitric Oxide Production
por: Gonon, Adrian T., et al.
Publicado: (2012) -
Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury
por: Shosha, Esraa, et al.
Publicado: (2016) -
Red Blood Cells in Type 2 Diabetes Impair Cardiac Post-Ischemic Recovery Through an Arginase-Dependent Modulation of Nitric Oxide Synthase and Reactive Oxygen Species
por: Yang, Jiangning, et al.
Publicado: (2018) -
Endothelial arginase 2 mediates retinal ischemia/reperfusion injury by inducing mitochondrial dysfunction
por: Shosha, Esraa, et al.
Publicado: (2021) -
Red Blood Cell Peroxynitrite Causes Endothelial Dysfunction in Type 2 Diabetes Mellitus via Arginase
por: Mahdi, Ali, et al.
Publicado: (2020)